All posts in Biologics
Surgical sealant technology from HyperBranch gets CE Mark
Wound and surgical sealant developerHyperBranch Medical Technology has received the CE Mark for an applicator that delivers its sealant used in cranial and spinal surgeries. The Adherus AutoSpray Dural Sealant delivers HyperBranch’s dural sealant to prevent leaks of cerebrospinal fluid after the surgical …
Smith & Nephew Biologics new Joint Venture with Essex Woodlands – An Interview with Mark Augusti
We recently heard the news about Smith & Nephew selling 51% of their Biologics division to Essex Woodlands in a Joint Venture. We caught up with the new
BioRestorative (BRTX): Two Huge Markets, One Solid Business Model
BioRestorative Therapies Inc. (OTCQB: BRTX), an emerging leader in autologous adult stem cell treatments for the disc/spine, metabolic disorders, and obesity, operating alongside companies like Pluristem Therapeutics Inc.
Regentis Biomaterials Announces $10 Million Raised in Latest Round of Funding
OR AKIVA, Israel and PRINCETON, New Jersey, May 14, 2012 -- /PRNewswire/ -- Regentis Biomaterials Ltd., a privately held company focused on developing proprietary hydrogels for tissue regeneration, announced
Kensey Nash Agrees to Be Acquired by DSM for $38.50 per Share in Cash
DSM will commence all-cash tender offer in May
Tender Offer expected to be completed by June 30, 2012 EXTON, Pa., May 3, 2012 /PRNewswire/ -- Kensey Nash Corporation (Nasdaq: KNSY),
Arthrosurface reaches $100M mark
Franklin joint resurfacing company Arthrosurface Inc. announced today that for the first time, the 11-year-old company has surpassed $100 million in cumulative net revenue as of March 2012. The
Bone marrow holds key to stem cell breakthrough
PATIENTS suffering from spinal cord injury may soon find help in the form of stem cells drawn from their own bone marrow, thanks to a research project from
Amedica Corporation Launches Dynamic Bone™ and DryFlex Allograft Products Revolutionary Expandable Bone Graft and Resorbable Adhesion Barrier Broadens Company’s Portfolio of Distinctive Orthobiologics
SALT LAKE CITY, April 5, 2012 --/PRNewswire/ -- Amedica Corporation, a spinal and reconstructive implant and instrument manufacturer announced today that it will begin distribution of
BONESUPPORT’S New CEO Announces 100 Day Plan
LUND, Sweden, April 4, 2012 /PRNewswire via COMTEX/ -- BONESUPPORT, an emerging leader in injectable bone substitutes for orthopedic trauma, bone infections and instrument augmentation related to
Patterning Cells on Implants: The Future?
aap Implantate AG Licenses Proprietary Biomaterials Product to a World Leading Medical Technology Company
Berlin, Germany March 28, 2012 - aap Implantate AG (XETRA: AAQ.DE), a global medical device company focused on innovative trauma products and biomaterials for the orthopaedic market, announced on march
BONESUPPORT Launches New Web Site
LUND, Sweden, March 27, 2012 --/PRNewswire/ -- BONESUPPORT, an emerging leader in injectable bone substitutes for orthopedic trauma, bone infections and instrument augmentation related to orthopedic
Kuros, Synthes to Co-Develop Bioactive Materials for Specified Applications
Swiss biomaterials firm Kuros Biosurgery and Synthes inked a license and development agreement under which they will work together commercialize Kuros’ synthetic matrix technology in specified fields. Kuros is focused on
Families Sue Synthes Over Bone Cement
The families of two patients who died during surgery that used an unapproved Synthes, Inc. bone cement are suing. A lawsuit, filed against the company and former company executives
MiMedx releases AmnioFix Injectable
MiMedx Group Inc. announced the launch of its newest tissue product, AmnioFix Injectable, at the American Academy of Orthopaedic Surgeons 2012 Annual Meeting in San Francisco.